A patent (US Pat. 10,604,467) for a medical CBD L-Proline cocrystal published this week assigned to Artelo Biosciences. A cocrystal can have more desirable properties as a pharmaceutical such as increased bioavailability giving value to this IP asset.
Artelo Biosciences uses biopharmaceutical techniques to develop novel therapeutics designed to act on the endocannabinoid system. Discover other novel publications conveniently categorized and displayed on Magic Number’s Patent Radian™.
